2026-03-09 The Microdose (Berkeley)

Will the FDA ever fast-track psychedelic drugs? 5 Questions with drug regulation expert Daniel Eisenkraft Klein

Eisenkraft Klein discusses the FDA’s new accelerated drug review program.

External link. We are not responsible for the content.

Read more ↗

More From The Microdose (Berkeley)

2026-03-06 The Microdose (Berkeley)

AtaiBeckley’s MDMA product could treat social anxiety; HHS Secretary Kennedy talks psychedelics on Rogan podcast; WV Senate and SD legislature pass Compass trigger bills

Plus: Pilot study uses psilocybin for post-treatment Lyme disease and Psychedelic-assisted therapy bill rejected then...

2026-03-02 The Microdose (Berkeley)

Minds Before Brains

An excerpt from my new book

2026-02-27 The Microdose (Berkeley)

The FDA is changing the drug approval process; In a Senate hearing, Surgeon General nominee Casey Means was asked about psychedelics use

Plus: RAND survey shows that nearly a quarter of U.S. adults support legal use of psilocybin mushrooms; Reunion Neuro...

Latest News

2026-03-09 MAPS

MAPS Sends Expert Delegation to United Nations Commission on Narcotic Drugs

Vienna, Austria; March 9, 2026 —The Multidisciplinary Association for Psychedelic Studies (MAPS) will send senior aca...

Policy
2026-03-09 Psychedelics Today

Colorado’s Ibogaine Bill Could Be a Landmark — If It Respects the Plant’s Roots

HB26-1325 would create a state-supported ibogaine research program to study addiction and PTSD treatment, including f...

2026-03-09 Psychedelics Today

Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape

Jen Davenport joins Psychedelics Today to interview the CEO and co-founder Joe Moore about the growth of Psychedelics...

2026-03-09 Psychedelic Alpha

AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal

AtaiBeckley is in structured discussions with pharma companies and royalty investors about a potential partnership fo...

2026-03-09 DoubleBlind Magazine

Psilocybin Isn’t Legal Yet. So, Why Are States Writing Laws for It?

PLUS ketamine spoons, sleep tripping, and psilocybin vs. anti-depressants. [...] Read More... The post Psilocybin Isn...

2026-03-08 OPEN Foundation

The Therapeutic Potential of Psychedelics in the Treatment of Substance Use Disorders

Substance use disorders (SUDs) remain among the most persistent global public health challenges. Despite decades of p...